Factors associated with tuberculosis as an AIDS-defining disease in an immigration setting

Journal of Epidemiology

Volumn 21, Issue 2, 2011, Pages 108-113

  Martín, Vicente ^a   de Olalla, Patricia García ^b   Orcau, Angels ^b   Caylà, Joan A ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

AIDS; Epidemiology; Immigration; Tuberculosis

Indexed keywords

EID: 79953091083     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20100072     Document Type: Article

References (34)

1. Rieder HL. Epidemiology of tuberculosis in Europe. Eur Respir J Suppl. 1995;20:620s-32s.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-21.
3. de Colombani P, Banatvala N, Zaleskis R, Maher D. WHO regional office for Europe. European framework to decrease the burden of TB/HIV. Eur Respir J. 2004;24:493-501.
4. Del Amo J, Petruckevitch A, Phillips AN, De Cock KM, Stephenson J, Desmond N, et al. Risk factors for tuberculosis with AIDS in London: a case-control study. Int J Tuberc Lung Dis. 1999;3:12-7.
5. Brassard P, Remis RS. Incidence of tuberculosis among reported AIDS cases in Quebec from 1979 to 1996. CMAJ. 1999;160:1838-42.
6. Serraino D, Puro V, Boumis E, Angeletti C, Girardi E, Petrosillo N, et al. Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS:Europe, 1993-2000. AIDS. 2003;17:2109-16.
7. Ancelle-Park R. Expanded European AIDS case definition. Lancet. 1993;341:441.
8. Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, et al. Incidence of tuberculosis among HIVinfected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005;41:1772-82.
9. Crimi P, Macrina G, Saettone F, Turello W, Ramorino P, Gasparini R, et al. Epidemiological trend in tuberculosis in the Italian region of Liguria: Impact of immigration and AIDS. Eur J Public Health. 2005;15(4):339-42.
10. Ahmed AB, Abubakar I, Delpech V, Lipman M, Boccia D, Forde J, et al. The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999-2003. Thorax. 2007;62:672-6.
11. EuroHIV. HIV/AIDS Surveillance in Europe. Mid-year report 2006. Saint-Maurice: French Institute for Public Health Surveillance; 2007. No. 74.
12. McKenna MT, McCray E, Jones JL, Onorato IM, Castro KG. The fall after the rise: Tuberculosis in the United States, 1991 through 1994. Am J Public Health. 1998;88:1059-63.
13. Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I. GEMES (Spanish Multicenter Study Group of Seroconverters). Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS. 2003;17:353-9.
14. Jaén A, Casabona J, Esteve A, Miró JM, Tural C, Ferrer E, et al. Características clinicoepidemiológicas y tendencias en el tratamiento antirretroviral de una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana. Cohorte PISCIS. Med Clin (Barc). 2005;124:525-31.
15. Hernando A, García-Cerrada C, Pulido F, Rubio R, Hervás R, Cepeda C, et al. Infección por el VIH en emigrantes: diferencias clínico-epidemiológicas con la población autóctona en un área de salud de la Comunidad de Madrid (2001-2004). Enferm Infecc Microbiol Clin. 2007;25:441-5.
16. de la Fuente L, Bravo MJ, Toro C, Brugal MT, Barrio G, Soriano V, et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health. 2006 Jun;60(6):537-42.
17. Rodrigo T, Cayla JA, Galdos-Tanguis H, Garcia de Olalla P, Brugal MT, Jansa JM. Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis. 2001;5:432-40.
18. EuroHIV. HIV/AIDS Surveillance in Europe.End-year report. 1999, 2000, 2001, 2002, 2003 and 2004. Saint-Maurice: Institut de veille sanitaire. No. 62, 64, 66, 68, 70 and 71. ipnbe n Availaible in: http://www.eurohiv.org/. Visited 24.02.2007.
19. Jones JL, Burwen DR, Fleming PL, Ward JW. Tuberculosis among AIDS patients in the United States, 1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:293-7.
20. Triol I, Schwoebel V, Delmas MC, Pinget R, Laporte A, Brunet JB. Factors associated with tuberculosis at AIDS diagnosis in France. AIDS. 1996;10:223-8.
21. Laguardia J, Merchán-Hamann E. Factores de riesgo para la enfermedad tuberculosa en los casos de sida notificados en Brasil, 1980 a 2000. Rev Esp Salud Publica. 2003;77:553-65.
22. Hanna DB, Gupta LS, Jones LE, Thompson DM, Kellerman SE, Sackoff JE. AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care. 2007;19:264-72.
23. Caylà JA, Galdós-Tangüis H, Jansà JM, García de Olalla P, Brugal T, Pañelle H. Evolución de la tuberculosis en Barcelona (1987-1995). Influencia del virus de la inmunodeficiencia humana y de las medidas de control. Med Clin (Barc). 1998;111:608-15.
24. Martín V, Gonzalez P, Caylá JA, Mirabent J, Cañellas J, Pina JM, et al. Case-finding of pulmonary tuberculosis on admission to a penitentiary centre. Tuber Lung Dis. 1994;75:49-53.
25. Solsona J, Caylà JA, Verdú E, Estrada MP, Garcia S, Roca D, et al. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis. 2001;5:724-31.
26. March F, Coll P, Guerrero RA, Busquets E, Caylà JA, Prats G. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS. 2000;14:525-35.
27. Martín V, Guerra JM, Caylà JA, Rodríguez JC, Blanco MD, Alcoba M. Incidence of tuberculosis and treatment of latent tuberculosis infection in a spanish prison population. Int J Tuberc Lung Dis. 2001;5:926-32.
28. Antonucci G, Girardi E, Raviglione M, Vanacore P, Angarano G, Chirianni A, et al. Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. GISTA (Gruppo Italiano di Studio Tubercolosi e AIDS). Eur Respir J. 2001;18:369-75.
29. Dore GJ, Li Y, McDonald A, Kaldor JM. Spectrum of AIDSdefining illnesses in Australia, 1992 to 1998: influence of country/region of birth. J Acquir Immune Defic Syndr. 2001;26:283-90.
30. Velasco M, Castilla V, Cervero M, Sanz J, Condes E, Gaspar G, et al. The changing pattern of tuberculosis and HIV coinfection in immigrants and Spaniards in the last 20 years. HIV Med. 2008;9:227-33.
31. Castilla J, Guevara M. Inmigración y virus de la inmunodeficiencia humana en España. Enferm Infecc Microbiol Clin. 2009;27(7):375-6.
32. Centro Nacional de Epidemiología. Valoración de los nuevos diagnósticos de VIH en España a partir de los sistemas de notificación de casos de las CCAA, periodo 2003-2007. Madrid: Instituto de Salud Carlos III; 2008 [citado5 Mar2009]. Disponible en: URL: http://www.isciii.es/htdocs/pdf/nuevos_diagnosticos_ccaa.pdf.
33. Farchi S, Mantovani J, Borgia P, Giorgi Rossi P. Tuberculosis incidence, hospitalisation prevalence and mortality in Lazio, Italy, 1997-2003. Int J Tuberc Lung Dis. 2008;12(2):193-8.
34. Oliva J, Galindo S, Vives N, Arillaga A, Izquierdo A, Nicolau A, et al. Retraso diagnóstico de la infección por el virus de la inmunodeficiencia humana en España. Enferm Infecc Microbiol Clin. 2010;28(9):583-9.